PRR-Activating and MicroRNA-Inhibiting Molecules and Methods of Using Same

The present disclosure provides nucleic acid molecules, compositions, and pharmaceutical compositions comprising a pattern recognition receptor (PRR) agonist and a microRNA antagonist and methods treating or preventing cancer in a subject in need thereof, the method comprising administering to the s...

Full description

Saved in:
Bibliographic Details
Main Authors Lee, Youngju, Lee, Jaewoo
Format Patent
LanguageEnglish
Published 02.06.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure provides nucleic acid molecules, compositions, and pharmaceutical compositions comprising a pattern recognition receptor (PRR) agonist and a microRNA antagonist and methods treating or preventing cancer in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the nucleic acid molecules, compositions, and pharmaceutical compositions.
Bibliography:Application Number: US202017430991